Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) plans to hold a conference call on May 7, 2026, at 9:00 a.m. Mountain Time to discuss its first-quarter 2026 financial results. The company will issue a press release detailing the results and highlights prior to the call. Management will lead the discussion, followed by a question-and-answer session. Participants can join via Rapid Connect registration, operator-assisted dial-in, or a live webcast. A replay will be available through May 14.
The announcement comes as Energy Fuels strengthens its position as a leading U.S. critical materials company specializing in uranium, rare earth elements (REE), heavy mineral sands, vanadium, and medical isotope development. The company has been the top U.S. producer of natural uranium concentrate, supplying nuclear utilities, and owns the only fully licensed conventional uranium mill operating in the U.S.—the White Mesa Mill in Utah. At this mill, Energy Fuels also produces REE products and evaluates medical isotope recovery for emerging cancer therapies.
This earnings call is significant for investors and industry observers tracking the U.S. critical minerals supply chain. With geopolitical tensions and global demand for clean energy technologies increasing, domestic production of uranium and rare earths has become a strategic priority. Energy Fuels is also advancing three heavy mineral sands and rare earths projects: the Vara Mada Project in Madagascar, the Bahia Project in Brazil, and the Donald Project in Australia, the latter through a joint venture with Astron Limited. These international projects complement its domestic operations and position the company to meet growing demand for materials essential to electric vehicles, wind turbines, and nuclear power.
The company’s focus on medical isotopes adds another dimension, targeting the development of treatments for cancer. By evaluating recovery of isotopes at the White Mesa Mill, Energy Fuels could become a key player in the emerging field of targeted alpha therapy, which uses radioactive isotopes to destroy cancer cells while sparing healthy tissue.
For more details on the company’s latest news and updates, visit the company’s newsroom at http://ibn.fm/UUUU. The full press release regarding the conference call is available at https://ibn.fm/9wZAY.
